Bibhash is a venture capital fund manager, investor, company builder and board member with around decade and half of experience in biotech.
Prior to co-founding Sound Bioventures, he worked as an investor with the biotech practice of a large, diversified venture fund (NEA). Prior to that he has operating experience in business development, portfolio management and corporate strategy functions at both AstraZeneca and Johnson & Johnson. He has led multiple investments (including current Board Director roles at Arthex and Aboleris), been involved in private financings and IPOs (Including Cydan, PhaseBio, Surface Oncology, Ardelyx, Trevi, Polyneuron, Qpex Bio, Nightstar, Vesper, Achaogen) and multiple major in-licensing, divestiture and acquisitions and cross-border (Europe / US) deals and has had advisory roles in several life science incubators (August Care, Bio Innovation Institute and Toronto Innovation Accelerator Partnership). His education spans 3 continents culminating with a PhD in the biology of retinal degeneration from Baylor College of Medicine.
Based in Washington D.C., USA
